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eft Atrial Size
hysiologic Determinants and Clinical Applications
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ae K. Oh, MD, FACC,* A. Jamil Tajik, MD, FACC,† Teresa S. M. Tsang, MD, FACC*
ochester, Minnesota; Scottsdale, Arizona; and Durham, North Carolina
Left atrial (LA) enlargement has been proposed as a barometer of diastolic burden and a
predictor of common cardiovascular outcomes such as atrial fibrillation, stroke, congestive
heart failure, and cardiovascular death. It has been shown that advancing age alone does not
independently contribute to LA enlargement, and the impact of gender on LA volume can
largely be accounted for by the differences in body surface area between men and women.
Therefore, enlargement of the left atrium reflects remodeling associated with pathophysio-
logic processes. In this review, we discuss the normal size and phasic function of the left
atrium. Further, we outline the clinically important aspects and pitfalls of evaluating LA size,
and the methods for assessing LA function using echocardiography. Finally, we review the
determinants of LA size and remodeling, and we describe the evidence regarding the
prognostic value of LA size. The use of LA volume for risk stratification is an evolving
science. More data are required with respect to the natural history of LA remodeling in
disease, the degree of LA modifiability with therapy, and whether regression of LA size
translates into improved cardiovascular outcomes. (J Am Coll Cardiol 2006;47:2357–63)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.048© 2006 by the American College of Cardiology Foundation
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6here is strong evidence that left atrial (LA) enlargement,
s determined by echocardiography, is a robust predictor of
ardiovascular outcomes. Recently, it has been shown that
A volume provides a more accurate measure of LA size
han conventional M-mode LA dimension (1). To optimize
he use of LA volume for risk stratification, an understand-
ng of the physiologic determinants of LA size and the
ethods for accurate quantitation is pivotal. Recent guide-
ines from the American Society of Echocardiography
rovide clarification as to which of the multiple methods for
A volume quantitation should be used in clinical practice
2). Such a standardized approach for LA volume assess-
ent will be crucial for reproducible measures and commu-
ication of LA size between laboratories. Herein, we
resent an overview of LA size and function, and describe
he physiologic determinants and clinical implications of
A enlargement.
A PHASIC FUNCTION AND SIZE
he LA mechanical function can be described broadly by
hree phases within the cardiac cycle (3). First, during
entricular systole and isovolumic relaxation, the LA func-
ions as a “reservoir” that receives blood from pulmonary
enous return and stores energy in the form of pressure.
From the *Division of Cardiovascular Diseases and Internal Medicine, Mayo
linic, Rochester, Minnesota; †Division of Cardiovascular Diseases, Mayo Clinic,
cottsdale, Arizona; and ‡Cardiovascular Medicine Division, Duke University,
urham, North Carolina.
Manuscript received November 18, 2005; revised manuscript received January 27,
006, accepted February 7, 2006.econd, during the early phase of ventricular diastole, the
A operates as a “conduit” for transfer of blood into the left
entricle (LV) after mitral valve opening via a pressure
radient, and through which blood flows passively from
he pulmonary veins into the left ventricle during LV
iastasis. Third, the “contractile” function of the LA
ormally serves to augment the LV stroke volume by
pproximately 20% (4). The relative contribution of this
booster pump” function becomes more dominant in the
etting of LV dysfunction (5,6).
The size of the LA varies during the cardiac cycle (7–11).
enerally, only maximum LA size is routinely measured in
linical practice. However, various LA volumes (8–11) can
e used to describe LA phasic function:
. Maximum LA volume occurs just before mitral valve
opening.
. Minimum LA volume occurs at mitral valve closure.
. Total LA emptying volume is an estimate of reservoir
volume, which is calculated as the difference between
maximum and minimum LA volumes.
. LA passive emptying volume is calculated as the differ-
ence between maximal LA volume and the LA volume
preceding atrial contraction (at the onset of the P-wave
on electrocardiography).
. LA active emptying (contractile) volume is calculated as
the difference between pre-atrial contraction LA volume
and minimum LA volume.
. LA (passive) conduit volume is calculated as the differ-
ence between LV stroke volume and the total LA
emptying volume.
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Left Atrial Size June 20, 2006:2357–63The relative contribution of LA phasic function to LV
lling is dependent upon the LV diastolic properties (12)
nd therefore varies with age (8). In subjects with normal
iastolic function, the relative contribution of the reservoir,
onduit, and contractile function of the LA to the filling of
he LV is approximately 40%, 35%, and 25%, respectively
12). With abnormal LV relaxation, the relative contribu-
ion of LA reservoir and contractile function increases and
onduit function decreases. However, as LV filling pressure
rogressively increases with advancing diastolic dysfunction,
he LA serves predominantly as a conduit (12).
able 1. Critical Elements and Common Pitfalls for Accurate M
Step Common Limitations/Errors
. Optimize LA
image quality
Atria are located in the far field of the a
Reduction of lateral resolution may re
apparently thicker LA walls.
. Obtain maximal LA size LA is foreshortened
. Timing of maximum
LA size
Correct frame for measurement is not se
. LA area planimetry LA border is inconsistently defined
. Long-axis LA length LA long axis is inconsistently delineated
. Interpretation Qualitative categorization of LA size
Abbreviations and Acronyms
2D  two-dimensional
3D  three-dimensional
AF  atrial fibrillation
CHF  congestive heart failure
LA  left atrial/atrium
LV  left ventricle/ventricular
PVar  pulmonary venous flow reversal during atrial
systole
PVd  pulmonary venous flow during early ventricular
diastole
PVs1  pulmonary venous flow during early ventricular
systole
PVs2  pulmonary venous flow during late ventricular
systoleAlso see the Appendix.
LA  left atrial.SSESSMENT OF LA SIZE AND FUNCTION
wo-dimensional and Doppler methods have been used
ncreasingly for the assessment of LA size and function,
espectively.
A size assessment. Measurement of anteroposterior LA
inear dimension by M-mode echocardiography (13,14) is
imple and convenient but not reliably accurate, given that
he LA is not a symmetrically shaped three-dimensional
3D) structure (15). Furthermore, because LA enlargement
ay not occur in a uniform fashion (16), one-dimensional
ssessment is likely to be an insensitive assessment of any
hange in LA size. In contrast to LA dimension, LA
olume by two-dimensional (2D) or 3D echocardiography
rovides a more accurate and reproducible estimate of LA
ize, when compared with reference standards such as
agnetic resonance imaging (MRI) and cine computerized
omography (CT) (17–20), and has a stronger association
ith cardiovascular outcomes (1,21,22). Accordingly, the
merican Society of Echocardiography has recommended
uantification of LA size by biplane 2D echocardiography
sing either the method of discs (by Simpson’s rule) or the
rea-length method (2). Although we have routinely used
he area-length method in our laboratory, we have found
hat the biplane Simpson’s method is comparable in accu-
acy and reproducibility. Critical elements and common
itfalls for accurate and reproducible measurement of bi-
ement and Interpretation of Maximum LA Volume*
Suggestions
views. Not improved by modifying the gain settings:
Increase in gain will further reduce LA lumen size
Decrease in gain may lead to image “drop out” and difficulties
in planimetry of LA area
Use high resolution sample box to increase pixel density and
facilitate accurate tracing of the endocardial border
Capture at least five beats for each cine loop to maximize
likelihood of obtaining adequate image quality
Modify transducer angulation or location (place the transducer
one intercostal space lower) until LA image is optimized
and not foreshortened
If discrepancy in the two lengths measured from the orthogonal
planes is 5 mm, acquisition should be repeated until the
discrepancy is reduced
Choose frame just before mitral valve opening
Consistently adhere to convention:
Inferior LA border—plane of mitral annulus (not the tip
of leaflets)
Exclude atrial appendage and confluences of pulmonary veins
Consistently adhere to convention:
Inferior margin—midpoint of mitral annulus plane
Superior (posterior) margin—midpoint of posterior LA wall
LA volume indexed to body surface area is optimally
interpreted as a continuous variable (using a reference
point of 22  5 ml/m2 as “normal”)easur
pical
sult in
lected
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June 20, 2006:2357–63 Left Atrial Sizelane LA volume assessment are detailed in the Appendix
nd outlined in Table 1.
Echocardiographic methods systematically underestimate
A volume when compared with CT (23) or MRI quanti-
ation (19), which in turn underestimates true LA size (11).
ore recently, magnetic electroanatomic mapping has also
een used for assessment of LA volume (24). However,
ecause of its portability and safety, echocardiographic
ssessment of LA volume is preferable to other imaging
ethods in clinical practice.
A volume reference limits. Reference values for 2D
chocardiographic maximum LA volumes have been esti-
ated using data collected on persons free of cardiovascular
isease, although few samples have been population based
21,25). Published reference values for maximum and min-
mum LA volumes are 22  6 ml/m2 (26) and 9  4 ml/m2
27), respectively. In a study of LA function, mean total LA
mptying volume was 13.5  4.3 ml/m2 (representing 37 
3% of LV stroke volume), fractional emptying of the LA
as 65  9%, and conduit volume was 23  8 ml/m2 (28).
ssessment of LA function by echocardiography. Pulsed-
ave Doppler evaluation of transmitral and pulmonary
enous blood flow velocity can be used for assessment of LA
unction, in addition to its widespread use for the evaluation
f LV diastolic function and filling pressure (29–31). The
ormal pulmonary venous flow pattern reflects flow from
he pulmonary veins to the LA during early ventricular
ystole (PVs1; seen distinctly in about 30% of transthoracic
chocardiography studies [32]), late ventricular systole and
sovolumic relaxation (PVs2), early ventricular diastole
PVd), and reversal of flow from the left atrium to pulmo-
ary veins during atrial systole (PVar). Apart from flow in
ate ventricular systole (reflected by PVs2), which represents
ropagation of the right ventricular pressure pulse through
he pulmonary circulation (33), blood flow in the pulmonary
eins is determined by events that regulate phasic LA
ressure (34). The magnitude and velocity-time integral of
he PVs waves reflect LA reservoir function and are deter-
ined by LV systolic function and LA relaxation (PVs1),
A compliance (PVs1 and PVs2), and right ventricular
troke volume (PVs2) (33). Peak velocity and velocity-time
ntegral of PVd is an index of LA conduit function (35) and
s dependent on factors that influence LA afterload: LV
elaxation and early filling (12) and mechanical obstruction
rom the mitral valve apparatus (36). During LA contrac-
ion, blood is ejected from the LA into the LV and the
ulmonary veins. Thus, assessment of transmitral (peak
-wave velocity, A-wave velocity-time integral, and atrial
lling fraction) (6,37) and pulmonary venous blood flow
PVar) (38) provides additive information for the evaluation
f LA booster pump function. More recently, global and
egional atrial contractile function has been evaluated with
ulse wave and color tissue Doppler imaging (8), but the
ncremental clinical utility of this assessment remains to be
etermined. Further, new echocardiographic techniques,
uch as with automated border detection using acoustic wuantification, are being developed to facilitate evaluation of
A size and function (8).
ETERMINANTS OF LA SIZE AND REMODELING
emographic and anthropometric influences. Body size
s a major determinant of LA size. To adjust for this
nfluence, LA size should be indexed to a measure of body
ize, most commonly to body surface area (21,25). It
emains to be clarified if this approach attenuates obesity-
elated variations in LA volume, which may be prognosti-
ally significant (39). Gender differences in LA size are
early completely accounted for by variation in body size
8,21,40,41). In persons free of cardiovascular disease,
ndexed LA volume is independent of age from childhood
nward (42). Indeed, age-related LA enlargement is a
eflection of the pathophysiologic perturbations that often
ccompany advancing age rather than a consequence of
hronologic aging (9). The relation of LA size to race or
thnicity has not been sufficiently studied.
trial structural remodeling. Many conditions are associ-
ted with LA remodeling and dilatation. The atria will
nlarge in response to two broad conditions: pressure and
olume overload. The relationship between increased LA
ize and increased filling pressures has been validated
gainst invasive measures in subjects with (43,44) and
ithout (30,45) mitral valve disease. Left atrial enlargement
ue to pressure overload is usually secondary to increased
A afterload, in the setting of mitral valve disease or LV
ysfunction. Case reports have suggested that LA dilatation
an also occur in response to pressure overload resulting
rom fibrosis and/or calcification of the LA. This condition,
nown as “stiff LA syndrome” (46,47), causes a reduction of
A compliance, a marked increase in LA and pulmonary
ressures, and right heart failure. Chronic volume overload
ssociated with conditions such as valvular regurgitation,
rteriovenous fistulas, and high output states including
hronic anemia and athletic heart (48,49), can also contrib-
te to generalized chamber enlargement. Both volume and
ressure overload can increase atrial size. However, pressure
verload is uniformly accompanied by abnormal myocyte
elaxation, while volume overload is characteristically asso-
iated with normal myocardial relaxation physiology.
A volume as an expression of LV filling pressures. In
ubjects without primary atrial pathology or congenital heart
r mitral valve disease, increased LA volume usually reflects
levated ventricular filling pressures. During ventricular
iastole, the LA is exposed to the pressures of the LV. With
ncreased stiffness or noncompliance of the LV, LA pressure
ises to maintain adequate LV filling (50), and the increased
trial wall tension leads to chamber dilatation and stretch of
he atrial myocardium. Thus, LA volume increases with
everity of diastolic dysfunction (22,51). The structural
hanges of the LA may express the chronicity of exposure to
bnormal filling pressures (22,45) and provide predictive
nformation beyond that of diastolic function grade (52),
hich is determined from evaluating multiple load-dependent
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Left Atrial Size June 20, 2006:2357–63arameters and therefore reflective of the instantaneous LV
iastolic function and filling pressures. In this way, analogous
o the relationship between hemoglobin A1C and random
lucose levels, LA volume reflects an average effect of LV
lling pressures over time, rather than an instantaneous
easurement at the time of study (53). Thus, Doppler and
issue Doppler assessment of instantaneous filling pressure
s better suited for monitoring hemodynamic status in the
hort term, whereas LA volume is useful for monitoring
ong-term hemodynamic control.
Left atrial size as an expression of diastolic function and
lling pressures has not been fully evaluated in specific
onditions. Most studies of LA size and outcomes have
xcluded patients with atrial fibrillation (AF). The relation-
hip between AF and LA volume is complex (54). It has
een difficult to establish the causal relationship between
F and LA structural remodeling. In patients with AF and
ardiac disease, structural LA alterations may be related to
he underlying cardiac pathophysiology rather than solely
he arrhythmia itself (55,56). Experimental animal studies
ave documented that sustained atrial tachyarrhythmias
nduce electrical, contractile and structural remodeling (57).
n some cases, it appears that LA structural remodeling may
e related to high ventricular rate and increased ventricular
lling pressures rather than to the atrial tachyarrhythmia
tself (58,59). However, in other individuals, the size of the
A varies widely for given LV relaxation and filling prop-
rties, suggesting a hysteresis between LA size and filling
ressures. Few studies have assessed the impact of sustained
able 2. Maximum Left Atrial Volume as a Predictor of Cardiov
Author
(Year Published) (Ref. #) Study Design
Study
Population
sang et al. (2001) (62) Retrospective cohort Clinic based 
sang et al. (2002) (63) Retrospective cohort Clinic based 
ossi et al. (2002) (64) Prospective cohort DCM patients 
sang et al. (2003) (65) Retrospective cohort Clinic based 
oller et al. (2003) (66) Retrospective cohort AMI patients 
sang et al. (2004) (67) Retrospective cohort Mild LVDD
patients
ani et al. (2004) (68) Case control HCM patients 
osi et al. (2004) (69) Prospective cohort HCM patients 
arnes et al. (2004) (70) Retrospective cohort Clinic based 
einart et al. (2004) (71) Prospective cohort AMI patients 
abharwal et al. (2004) (72) Prospective cohort ICM patients 
akemoto et al. (2005) (73) Retrospective cohort Clinic based 
ottdiener et al. (2006) (74) Prospective cohort Community
based
sang et al. (2006) (75) Prospective cohort Clinic based 
ll discriminatory limits have been indexed to body surface area. *Atrial fibrillation
ransient ischemic attack, stroke, or cardiovascular death.
A-L  area length method (biplane unless specified); AMI  acute myocardia
entricular diastolic dysfunction; HCM  hypertrophic cardiomyopathy; ICM  isch
ethod; Tx  transplantation.F on atrial structure in patients with lone AF (60). fA SIZE FOR THE PREDICTION
F CARDIOVASCULAR OUTCOMES
here is considerable data confirming the relationship
etween increased LA size, principally maximal but also
inimal (30,61), and the development of adverse cardio-
ascular outcomes in subjects without a history of AF or
ignificant valvular disease (62–75) (Table 2).
F. Atrial fibrillation is the most common of the serious
ardiac arrhythmias and is associated with increased
orbidity and mortality in the community. Prospective
ata from the large population-based studies have estab-
ished a relationship between M-mode anteroposterior
A diameter and the risk of developing AF (76,77). In
he Framingham study, a 5-mm incremental increase in
nteroposterior LA diameter was associated with a 39%
ncreased risk for subsequent development of AF (76). In
he Cardiovascular Health Study, subjects in sinus
hythm with an anteroposterior LA diameter 5.0 cm
ad approximately four times the risk of developing AF
uring the subsequent period of surveillance (77). More
ecently, LA volume has been shown to predict AF in
atients with cardiomyopathy (68,69) and first-diagnosed
onvalvular AF in a random sample of elderly Olmsted
ounty residents who had undergone investigation with
 clinically indicated echocardiogram (62,63). The rela-
ionship between LA volume and LA dimension was
onlinear (68), and it has been confirmed that LA
olume represented a superior measure over LA diameter
ar Outcomes
Sample Size
(Age, yrs)
Study
Outcome
Volume
Method
Discriminatory
Threshold
(ml/m2)
Risk
Ratio
,655 (75  7) AF A-L Quartiles —
840 (75  7) AF A-L Tertiles —
337 (60  13) Death or
heart Tx
A-L 68.5 3.8
,160 (75  7) Combined
events*
A-L 32 —
314 (32–94) Death A-L 32 6.1
569 (76  7) AF, CHF A-L 27 —
141 (61  13) AF A-L 34 —
150 (4–83) AF A-L 27 —
,554 (75  7) Ischemic
stroke
A-L 32 1.6
395 (62  12) Death MOD 32 2.2
109 (63  9) Death PE 60 —
,495 (75  7) CHF A-L 32 2.0
851 (78  6) CHF PE Quartiles —
423 (71  8) Combined
events*
A-L 34–40 3.2
40 6.6
, myocardial infarction, congestive heart failure (CHF), coronary revascularization,
tion; BSA  body surface area; DCM  dilated cardiomyopathy; LVDD  left
ardiomyopathy; MOD  method of discs by Simpson’s rule; PE  prolate-ellipsoidascul
1
1
1
1
(AF)
l infarcor predicting outcomes including AF (62,68,75) and
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June 20, 2006:2357–63 Left Atrial Sizerovided prognostic information that was incremental to
linical risk factors (62).
troke. Stroke is the leading cause of severe long-term
isability and the third largest contributor to mortality in
he U.S. (78). Despite the strong association between AF
nd ischemic stroke, 85% of strokes occur in patients who
re in apparent sinus rhythm (78). In the general popula-
ion, LA size has been determined to be a predictor of
troke and death (79). Increased LA volume has also been
hown to predict the onset of first stroke in clinic-based
lderly persons who were in sinus rhythm and did not have
history of ischemic neurologic events, AF, or valvular heart
isease (70). Even after censoring for the development of
ocumented AF, an indexed LA volume 32 ml/m2 was
ssociated with an increased stroke risk (hazard ratio [HR]
.67, 95% confidence interval [CI] 1.08 to 2.58) over 4.3 
.7 years, independent of age and other clinical risk factors
or cerebrovascular disease.
eart failure. As previously discussed, LA volume is a
arometer of LV filling pressure and reflects the burden of
iastolic dysfunction in subjects without AF or significant
alvular disease (22). Elevation of filling pressure is uni-
ormly found in the presence of symptomatic congestive
eart failure (CHF). Because the majority of individuals in
he community with LV dysfunction (systolic or “isolated”
iastolic) are in a preclinical phase of the disease (80),
ethods to quantify the risk of progression to symptomatic
eart failure would be clinically useful. Evidence for a
rognostic role for LA volume to predict incident CHF is
merging (73,74). In a large prospective, population-based
tudy, subjects with incident CHF during follow-up had
lightly higher baseline LA linear diameters (39 mm vs. 37
m for women [p  0.01], 41 mm vs. 39 mm for men [p
 0.01]) (81). In a study of older adults referred for
chocardiography, LA volume 32 ml/m2 was associated
ith increased incidence of CHF, independent of age,
yocardial infarction, diabetes mellitus, hypertension, LV
ypertrophy, and mitral inflow velocities (HR 1.97, 95% CI
.4 to 2.7) (73). Furthermore, in subjects with an LV
jection fraction 50% at baseline and within four weeks of
ncident CHF, there was an increase of 8 ml/m2 in LA
olume from baseline to CHF diagnosis, reflecting the
dded burden of diastolic dysfunction during the period of
ransition from preclinical to clinical status.
ortality. The relationship between LA size and death
as been demonstrated in high-risk groups, such as patients
ith dilated cardiomyopathy (64), LV dysfunction (82),
trial arrhythmias (83), acute myocardial infarction
66,71), and patients undergoing valve replacement for
ortic stenosis (84) and mitral regurgitation (85). The LA
iameter has also been shown to independently predict
eath in the general population (81). However, in other
opulation-based studies, the relationship between LA size
nd death has been attenuated when LV mass (79), LV
ypertrophy (86), or diastolic function (51) has been con-
idered. Thus, owing to the intimate relationship betweenA volume, LV mass/hypertrophy, and diastolic dysfunc-
ion, the incremental value of each parameter for the
rediction of death is diminished when considering the
thers.
Although a dilated LA is associated with a number of
dverse outcomes, there is increasing evidence suggesting
hat LA size is potentially modifiable with medical therapy
87–96), but whether LA size reduction translates to im-
roved outcomes remains to be established.
ONCLUSIONS
eft atrial enlargement carries important clinical and prog-
ostic implications. Left atrial volume is superior to LA
iameter as a measure of LA size, and should be incorpo-
ated into routine clinical evaluation. Future studies are
arranted to further our understanding of the natural
istory of LA remodeling, the extent of reversibility of LA
nlargement with medical therapy, and the impact of such
hanges on outcomes. The utility of LA volume and
unction for monitoring cardiovascular risk and for guiding
herapy is an evolving science and may prove to have a very
mportant public health impact.
eprint requests and correspondence: Dr. Teresa S. M. Tsang,
ivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street
W, Rochester, Minnesota 55905. E-mail: tsang.teresa@mayo.edu.
EFERENCES
1. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical
practice and in research studies to determine left atrial size. Am J
Cardiol 1999;84:829–32.
2. Lang RM, Bierig M, Devereux RB, et al. Recommendations for
chamber quantification: a report from the American Society of
Echocardiography’s Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction
with the European Association of Echocardiography, a branch of the
European Society of Cardiology. J Am Soc Echocardiogr 2005;18:
1440–63.
3. Pagel PS, Kehl F, Gare M, Hettrick DA, Kersten JR, Warltier DC.
Mechanical function of the left atrium: new insights based on analysis
of pressure-volume relations and Doppler echocardiography. Anesthe-
siology 2003;98:975–94.
4. Mitchell JH, Shapiro W. Atrial function and the hemodynamic
consequences of atrial fibrillation in man. Am J Cardiol 1969;23:
556 – 67.
5. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow
velocity patterns to left ventricular diastolic function: new insights
from a combined hemodynamic and Doppler echocardiographic study.
J Am Coll Cardiol 1988;12:426–40.
6. Thomas L, Levett K, Boyd A, Leung DY, Schiller NB, Ross DL.
Compensatory changes in atrial volumes with normal aging: is atrial
enlargement inevitable? J Am Coll Cardiol 2002;40:1630–5.
7. Braunwald E, Frahm C. Studies on Starling’s law of the heart, IV:
observations on the hemodynamic functions of the left atrium in man.
Circulation 1961;24:633–42.
8. Spencer KT, Mor-Avi V, Gorcsan IJ, et al. Effects of aging on left
atrial reservoir, conduit, and booster pump function: a multi-
institution acoustic quantification study. Heart 2001;85:272–7.
9. Thomas L, Levett K, Boyd A, Leung DYC, Schiller NB, Ross DL.
Changes in regional left atrial function with aging: evaluation by
Doppler tissue imaging. Eur J Echocardiogr 2003;4:92–100.
0. Nikitin NP, Witte KKA, Thackray SDR, Goodge LJ, Clark AL,
Cleland JGF. Effect of age and sex on left atrial morphology and
function. Eur J Echocardiogr 2003;4:36–42.
11
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
2362 Abhayaratna et al. JACC Vol. 47, No. 12, 2006
Left Atrial Size June 20, 2006:2357–631. Jarvinen V, Kupari M, Hekali P, Poutanen VP. Assessment of left
atrial volumes and phasic function using cine magnetic resonance
imaging in normal subjects. Am J Cardiol 1994;73:1135–8.
2. Prioli A, Marino P, Lanzoni L, Zardini P. Increasing degrees of left
ventricular filling impairment modulate left atrial function in humans.
Am J Cardiol 1998;82:756–61.
3. Hirata T, Wolfe SB, Popp RL, Helmen CH, Feigenbaum H.
Estimation of left atrial size using ultrasound. Am Heart J 1969;78:
43–52.
4. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations
regarding quantitation in M-mode echocardiography: results of a
survey of echocardiographic measurements. Circulation 1978;58:
1072–83.
5. Schabelman S, Schiller N, Anschuetz R, Silverman N, Glantz S.
Comparison of four two-dimensional echocardiographic views for
measuring left atrial size (abstr). Am J Cardiol 1978;41:391.
6. Lemire F, Tajik AJ, Hagler DJ. Asymmetric left atrial enlargement; an
echocardiographic observation. Chest 1976;69:779–81.
7. Kircher B, Abbott JA, Pau S, et al. Left atrial volume determination by
biplane two-dimensional echocardiography: validation by cine com-
puted tomography. Am Heart J 1991;121:864–71.
8. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB. Reproduc-
ibility of quantitative two-dimensional echocardiography. Am Heart J
1988;115:425–31.
9. Rodevan O, Bjornerheim R, Ljosland M, Maehle J, Smith HJ, Ihlen
H. Left atrial volumes assessed by three- and two-dimensional echocar-
diography compared to MRI estimates. Int J Card Imaging 1999;15:
397–410.
0. Poutanen T, Jokinen E, Sairanen H, Tikanoja T. Left atrial and left
ventricular function in healthy children and young adults assessed by
three dimensional echocardiography. Heart 2003;89:544–9.
1. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR,
Redfield MM. Left atrial volume as an index of left atrial size: a
population-based study. J Am Coll Cardiol 2003;41:1036–43.
2. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial
volume as a morphophysiologic expression of left ventricular diastolic
dysfunction and relation to cardiovascular risk burden. Am J Cardiol
2002;90:1284–9.
3. Vandenberg BF, Weiss RM, Kinzey J, et al. Comparison of left atrial
volume by two-dimensional echocardiography and cine-computed
tomography. Am J Cardiol 1995;75:754–7.
4. Patel VV, Ren JF, Jeffery ME, Plappert TJ, St John Sutton MG,
Marchlinski FE. Comparison of left atrial volume assessed by mag-
netic endocardial catheter mapping versus transthoracic echocardiog-
raphy. Am J Cardiol 2003;91:351–4.
5. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution
and categorization of echocardiographic measurements in relation to
reference limits: the Framingham Heart Study: formulation of a
height- and sex-specific classification and its prospective validation.
Circulation 1997;96:1863–73.
6. Schiller N, Foster E. Analysis of left ventricular systolic function.
Heart 1996;75 Suppl 2:17–26.
7. Triposkiadis F, Tentolouris K, Androulakis A, et al. Left atrial
mechanical function in the healthy elderly: new insights from a
combined assessment of changes in atrial volume and transmitral flow
velocity. J Am Soc Echocardiogr 1995;8:801–9.
8. Gutman J, Wang YS, Wahr D, Schiller NB. Normal left atrial
function determined by 2-dimensional echocardiography. Am J Car-
diol 1983;51:336–40.
9. Appleton CP, Gonzalez MS, Basnight MA. Relationship of left atrial
pressure and pulmonary venous flow velocities: importance of baseline
mitral and pulmonary venous flow velocity patterns studied in lightly
sedated dogs. J Am Soc Echocardiogr 1994;7:264–75.
0. Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight
MA. Estimation of left ventricular filling pressures using two-
dimensional and Doppler echocardiography in adult patients with
cardiac disease. Additional value of analyzing left atrial size, left atrial
ejection fraction and the difference in duration of pulmonary venous
and mitral flow velocity at atrial contraction. J Am Coll Cardiol
1993;22:1972–82.
1. Basnight MA, Gonzalez MS, Kershenovich SC, Appleton CP. Pul-
monary venous flow velocity: relation to hemodynamics, mitral flow
velocity and left atrial volume, and ejection fraction. J Am Soc
Echocardiogr 1991;4:547–58.2. Jensen JL, Williams FE, Beilby BJ, et al. Feasibility of obtaining
pulmonary venous flow velocity in cardiac patients using transthoracic
pulsed wave Doppler technique. J Am Soc Echocardiogr 1997;10:
60–6.
3. Smiseth OA, Thompson CR, Lohavanichbutr K, et al. The pulmonary
venous systolic flow pulse—its origin and relationship to left atrial
pressure. J Am Coll Cardiol 1999;34:802–9.
4. Appleton CP. Hemodynamic determinants of Doppler pulmonary
venous flow velocity components: new insights from studies in lightly
sedated normal dogs. J Am Coll Cardiol 1997;30:1562–74.
5. Castello R, Pearson AC, Lenzen P, Labovitz AJ. Evaluation of
pulmonary venous flow by transesophageal echocardiography in sub-
jects with a normal heart: comparison with transthoracic echocardiog-
raphy. J Am Coll Cardiol 1991;18:65–71.
6. Chen YT, Kan MN, Lee AY, Chen JS, Chiang BN. Pulmonary
venous flow: its relationship to left atrial and mitral valve motion. J Am
Soc Echocardiogr 1993;6:387–94.
7. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler
evaluation of atrial mechanical function after electrical cardioversion of
atrial fibrillation. J Am Coll Cardiol 1989;13:617–23.
8. Nakatani S, Garcia MJ, Firstenberg MS, et al. Noninvasive assess-
ment of left atrial maximum dP/dt by a combination of transmitral
and pulmonary venous flow. J Am Coll Cardiol 1999;34:795–
801.
9. Vasan RS, Levy D, Larson MG, Benjamin EJ. Interpretation of
echocardiographic measurements: a call for standardization. Am
Heart J 2000;139:412–22.
0. Wang Y, Gutman JM, Heilbron D, Wahr D, Schiller NB. Atrial
volume in a normal adult population by two-dimensional echocardi-
ography. Chest 1984;86:595–601.
1. Knutsen KM, Stugaard M, Michelsen S, Otterstad JE. M-mode
echocardiographic findings in apparently healthy, nonathletic Norwe-
gians aged 20–70 years. Influence of age, sex and body surface area.
J Intern Med 1989;225:111–5.
2. Pearlman JD, Triulzi MO, King ME, Abascal VM, Newell J,
Weyman AE. Left atrial dimensions in growth and development:
normal limits for two-dimensional echocardiography. J Am Coll
Cardiol 1990;16:1168–74.
3. Kennedy JW, Yarnall SR, Murray JA, Figley MM. Quantitative
angiocardiography. IV. Relationships of left atrial and ventricular
pressure and volume in mitral valve disease. Circulation 1970;41:
817–24.
4. Pape LA, Price JM, Alpert JS, Ockene IS, Weiner BH. Relation of left
atrial size to pulmonary capillary wedge pressure in severe mitral
regurgitation. Cardiology 1991;78:297–303.
5. Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul
S. Relationship between left ventricular wall thickness and left atrial
size: comparison with other measures of diastolic function. J Am Soc
Echocardiogr 1995;8:37–47.
6. Mehta S, Charbonneau F, Fitchett DH, Marpole DG, Patton R,
Sniderman AD. The clinical consequences of a stiff left atrium. Am
Heart J 1991;122:1184–91.
7. Pilote L, Huttner I, Marpole D, Sniderman A. Stiff left atrial
syndrome. Can J Cardiol 1988;4:255–7.
8. Hoogsteen J, Hoogeveen A, Schaffers H, Wijn PF, van der Wall EE.
Left atrial and ventricular dimensions in highly trained cyclists. Int
J Cardiovasc Imaging 2003;19:211–7.
9. Lai ZY, Chang NC, Tsai MC, Lin CS, Chang SH, Wang TC. Left
ventricular filling profiles and angiotensin system activity in elite
baseball players. Int J Cardiol 1998;67:155–60.
0. Greenberg B, Chatterjee K, Parmley WW, Werner JA, Holly AN.
The influence of left ventricular filling pressure on atrial contribution
to cardiac output. Am Heart J 1979;98:742–51.
1. Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL,
Redfield MM. Diastolic dysfunction and left atrial volume: a
population-based study. J Am Coll Cardiol 2005;45:87–92.
2. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left
ventricular function in clinical congestive heart failure. Am J Cardiol
1985;55:1032–6.
3. Douglas PS. The left atrium: a biomarker of chronic diastolic dysfunc-
tion and cardiovascular disease risk. J Am Coll Cardiol
2003;42:1206–7.
55
5
5
5
5
6
6
6
6
6
6
6
6
6
6
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
8
8
9
9
9
9
9
9
9
A
F
2363JACC Vol. 47, No. 12, 2006 Abhayaratna et al.
June 20, 2006:2357–63 Left Atrial Size4. Thamilarasan M, Klein AL. Factors relating to left atrial enlargement
in atrial fibrillation: “chicken or the egg” hypothesis (comment). Am
Heart J 1999;137:381–3.
5. Mary-Rabine L, Albert A, Pham TD, et al. The relationship of human
atrial cellular electrophysiology to clinical function and ultrastructure.
Circ Res 1983;52:188–99.
6. Thiedemann KU, Ferrans VJ. Left atrial ultrastructure in mitral
valvular disease. Am J Pathol 1977;89:575–604.
7. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural
remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230–46.
8. Schoonderwoerd BA, Ausma J, Crijns HJ, Van Veldhuisen DJ,
Blaauw EH, Van Gelder IC. Atrial ultrastructural changes during
experimental atrial tachycardia depend on high ventricular rate. J Car-
diovasc Electrophysiol 2004;15:1167–74.
9. Schoonderwoerd BA, Van Gelder IC, van Veldhuisen DJ, et al.
Electrical remodeling and atrial dilation during atrial tachycardia are
influenced by ventricular rate: role of developing tachycardiomyopathy.
J Cardiovasc Electrophysiol 2001;12:1404–10.
0. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri
A. Histological substrate of atrial biopsies in patients with lone atrial
fibrillation. Circulation 1997;96:1180–4.
1. Fatema K, Abhayaratna WP, Barnes ME, et al. Minimal left atrial
volume as a predictor of first atrial fibrillation/flutter in an elderly
cohort (abstr). Circulation 2005;112:585A.
2. Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important
risk marker of incident atrial fibrillation in 1,655 older men and
women. Mayo Clin Proc 2001;76:467–75.
3. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic
dysfunction as a predictor of the first diagnosed nonvalvular atrial
fibrillation in 840 elderly men and women. J Am Coll Cardiol
2002;40:1636–44.
4. Rossi A, Cicoira M, Zanolla L, et al. Determinants and prognostic
value of left atrial volume in patients with dilated cardiomyopathy.
J Am Coll Cardiol 2002;40:1425–30.
5. Tsang TS, Barnes ME, Gersh BJ, et al. Prediction of risk for first
age-related cardiovascular events in an elderly population: the
incremental value of echocardiography. J Am Coll Cardiol 2003;
42:1199 –205.
6. Moller JE, Hillis GS, Oh JK, et al. Left atrial volume: a powerful
predictor of survival after acute myocardial infarction. Circulation
2003;107:2207–12.
7. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Risks for
atrial fibrillation and congestive heart failure in patients 65 years of
age with abnormal left ventricular diastolic relaxation. Am J Cardiol
2004;93:54–8.
8. Tani T, Tanabe K, Ono M, et al. Left atrial volume and the risk of
paroxysmal atrial fibrillation in patients with hypertrophic cardiomy-
opathy. J Am Soc Echocardiogr 2004;17:644–8.
9. Losi MA, Betocchi S, Aversa M, et al. Determinants of atrial
fibrillation development in patients with hypertrophic cardiomyopa-
thy. Am J Cardiol 2004;94:895–900.
0. Barnes ME, Miyasaka Y, Seward JB, et al. Left atrial volume in the
prediction of first ischemic stroke in an elderly cohort without atrial
fibrillation. Mayo Clin Proc 2004;79:1008–14.
1. Beinart R, Boyko V, Schwammenthal E, et al. Long-term prognostic
significance of left atrial volume in acute myocardial infarction. J Am
Coll Cardiol 2004;44:327–34.
2. Sabharwal N, Cemin R, Rajan K, Hickman M, Lahiri A, Senior R.
Usefulness of left atrial volume as a predictor of mortality in patients
with ischemic cardiomyopathy. Am J Cardiol 2004;94:760–3.
3. Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial
volume in predicting first congestive heart failure in patients65 years
of age with well-preserved left ventricular systolic function. Am J
Cardiol 2005;96:832–6.
4. Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio
TA. Left atrial volume, geometry, and function in systolic and diastolic
heart failure of persons 65 years of age (the Cardiovascular Health
Study). Am J Cardiol 2006;97:83–9.
5. Tsang TS, Abhayaratna WP, Barnes ME, et al. Prediction of
cardiovascular outcomes with left atrial size: is volume superior to area
or diameter? J Am Coll Cardiol 2006;47:1018–23.
6. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic
predictors of nonrheumatic atrial fibrillation. The Framingham Heart
Study. Circulation 1994;89:724–30. p7. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors
for atrial fibrillation in older adults. Circulation 1997;96:2455–61.
8. American Heart Association. Heart Disease and Stroke Statistics—
2005 Update. Dallas, TX: American Heart Association, 2003.
9. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left
atrial size and the risk of stroke and death. The Framingham Heart
Study. Circulation 1995;92:835–41.
0. Redfield MM, Jacobsen SJ, Burnett JC Jr., Mahoney DW, Bailey KR,
Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction
in the community: appreciating the scope of the heart failure epidemic.
JAMA 2003;289:194–202.
1. Gardin JM, McClelland R, Kitzman D, et al. M-mode echocardio-
graphic predictors of six- to seven-year incidence of coronary heart
disease, stroke, congestive heart failure, and mortality in an elderly
cohort (the Cardiovascular Health Study). Am J Cardiol 2001;87:
1051–7.
2. Giannuzzi P, Temporelli PL, Bosimini E, et al. Independent and
incremental prognostic value of Doppler-derived mitral deceleration
time of early filling in both symptomatic and asymptomatic patients
with left ventricular dysfunction. J Am Coll Cardiol 1996;28:383–90.
3. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for
systemic embolization of atrial fibrillation without mitral stenosis.
Am J Cardiol 1990;65:1112–6.
4. Rossi A, Tomaino M, Golia G, et al. Usefulness of left atrial size in
predicting postoperative symptomatic improvement in patients with
aortic stenosis. Am J Cardiol 2000;86:567–70.
5. Reed D, Abbott RD, Smucker ML, Kaul S. Prediction of outcome
after mitral valve replacement in patients with symptomatic chronic
mitral regurgitation. The importance of left atrial size. Circulation
1991;84:23–34.
6. Laukkanen JA, Kurl S, Eranen J, Huttunen M, Salonen JT. Left
atrium size and the risk of cardiovascular death in middle-aged men.
Arch Intern Med 2005;165:1788–93.
7. Sanders P, Morton JB, Kistler PM, Vohra JK, Kalman JM, Sparks PB.
Reversal of atrial mechanical dysfunction after cardioversion of atrial
fibrillation: implications for the mechanisms of tachycardia-mediated
atrial cardiomyopathy. Circulation 2003;108:1976–84.
8. Raitt MH, Kusumoto W, Giraud G, McAnulty JH. Reversal of
electrical remodeling after cardioversion of persistent atrial fibrillation.
J Cardiovasc Electrophysiol 2004;15:507–12.
9. Hornero F, Rodriguez I, Buendia J, et al. Atrial remodeling after
mitral valve surgery in patients with permanent atrial fibrillation.
J Card Surg 2004;19:376–82.
0. Trikas A, Papathanasiou S, Tousoulis D, et al. Left atrial function,
cytokines and soluble apoptotic markers in mitral stenosis: effects of
valvular replacement. Int J Cardiol 2005;99:111–5.
1. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K.
Effects of angiotensin II type 1 receptor antagonist on electrical and
structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003;41:
2197–204.
2. Shinagawa K, Derakhchan K, Nattel S. Pharmacological prevention of
atrial tachycardia induced atrial remodeling as a potential therapeutic
strategy. Pacing Clin Electrophysiol 2003;26:752–64.
3. Tsao HM, Wu MH, Huang BH, et al. Morphologic remodeling of
pulmonary veins and left atrium after catheter ablation of atrial
fibrillation: insight from long-term follow-up of three-dimensional
magnetic resonance imaging. J Cardiovasc Electrophysiol 2005;16:
7–12.
4. Thomas L, Boyd A, Thomas SP, Schiller NB, Ross DL. Atrial
structural remodelling and restoration of atrial contraction after linear
ablation for atrial fibrillation. Eur Heart J 2003;24:1942–51.
5. Yalcin F, Aksoy FG, Muderrisoglu H, Sabah I, Garcia MJ, Thomas
JD. Treatment of hypertension with perindopril reduces plasma atrial
natriuretic peptide levels, left ventricular mass, and improves echocardio-
graphic parameters of diastolic function. Clin Cardiol 2000;23:437–41.
6. Tsang TS, Barnes ME, Abhayaratna WP, et al. Effects of quinapril on
left atrial structural remodeling and arterial stiffness. Am J Cardiol
2006;97:916–20.
PPENDIX
or the measurement of LA volume by echocardiography,
lease see the online version of this article.
